Venus Concept (VERO) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
29 Nov, 2025Management team and governance
CEO is Rajiv De Silva, with Domenic Della Penna as CFO and a board including Scott Barry, Louise Lacchin, Fritz LaPorte, Anthony Natale, M.D., Keith Sullivan, and Stanley Tyler Hollmig, M.D.
The registration statement was signed in Toronto, Ontario, Canada, on July 24, 2025.
Offering details and pricing
The registration statement is for a proposed public offering to commence as soon as practicable after effectiveness.
The company is a non-accelerated filer and a smaller reporting company.
Underwriters and syndicate
Legal counsel for the company is Dorsey & Whitney LLP, with Richard Raymer as a contact.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Venus Concept
- Revenue down 17% year-over-year, but debt reduced and margin improved amid ongoing risks.VERO
Q2 20241 Feb 2026 - Q3 2024 revenue fell 15% year-over-year as debt was cut by 54% and losses persisted.VEROQ3 202414 Jan 2026
- Revenue fell 13% in Q4 and 15% for FY24; debt cut by 47% and Q1 2025 revenue to exceed $14M.VEROQ4 202424 Dec 2025
- Shelf registration enables up to $30.4M in securities sales for global medical technology expansion.VERORegistration Filing16 Dec 2025
- Shareholders to vote on director elections, auditor ratification, and key share issuance proposals.VEROProxy Filing1 Dec 2025
- Shareholders to vote on director elections, auditor ratification, and major share issuances.VEROProxy Filing1 Dec 2025
- Vote sought on a reverse stock split to maintain Nasdaq listing and avoid delisting risk.VEROProxy Filing1 Dec 2025
- Vote sought to authorize a reverse stock split to maintain Nasdaq listing and enhance share value.VEROProxy Filing1 Dec 2025
- Approval sought for share issuance tied to convertible notes after major debt restructuring.VEROProxy Filing1 Dec 2025